<DOC>
	<DOCNO>NCT02720198</DOCNO>
	<brief_summary>This study 's primary objective compare efficacy tolerability switch patient inadequate relief generic SSRIs levomilnacipran versus add new treatment ( quetiapine ER ) exist treatment people diagnose depression ( major depression disorder ) . The secondary objective examine response remission rate follow switch generic SSRI levomilnacipran ER augmentation quetiapine along examine change neurocognitive apathy measure switch .</brief_summary>
	<brief_title>Levomilnacipran ER vs. Adjunctive Quetiapine ER Adults With Inadequate Relief With SSRIs MDD</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Age 1865 year inclusive Current diagnosis MDD base DSMIV criterion Able understand study rule procedure willing sign write informed consent study participation Inadequate response antidepressant : score ≥14 17item Hamilton Anxiety Scale ( HAMD ) ≥ 50 % reduction HAMD CGIS score baseline retrospective confirmation adequate trial single antidepressant ( define minimum 6week trial acceptable therapeutic dose ( daily dose ≥ 40 mg fluoxetine , 40 mg paroxetine , 20 mg citalopram , 10 mg escitalopram , 37.5 mg paroxetine CR , 150 mg sertraline , 100 mg fluvoxamine ) . If female , nonpregnant/nonlactating status Duration current MDD ≥ 4 week &lt; 24 month Not 2 treatment failure adequate antidepressant trial current episode MDD Has previously participate levomilnacipran ER quetiapine XR quetiapine clinical study previous 12 month Has 1 follow : Current past history : manic hypomanic episode , schizophrenia psychotic disorder define DSM 5 Diagnosis alcohol substance use disorder ( except nicotine caffeine ) define DSM5 sustain full remission least 6 month prior screen ( participant must also negative urine drug screen prior baseline ) . Presence history clinically significant neurological disorder ( include epilepsy ) Poorly control Hypertension Diabetes uncontrolled narrowangle glaucoma hypersensitivity levomilnacipran , milnacipran , quetiapine quetiapine XR Neurodegenerative disorder . Has thyroid stimulate hormone value outside normal range Screening Visit deem clinically significant investigator . Has clinically significant abnormal vital sign determine investigator . Has clinical significant abnormal electrocardiogram . Has screen laboratory value great 2.5 time upper low limit normal range judge clinically significant Has disease take medication , opinion investigator , could interfere assessment safety , tolerability , efficacy prevent individual completing study . Female subject childbearing potential adequate contraception method opinion investigator If female childbearing , must agree use appropriate contraceptive measure duration study one month afterwards . Medically acceptable contraceptive include : ( 1 ) surgical sterilization ( tubal ligation hysterectomy ) , ( 2 ) approve hormonal contraceptive ( birth control pill , patch , implant , injection ) , ( 3 ) barrier method ( condom diaphragm ) use spermicide , ( 4 ) intrauterine device ( IUD ) . Contraceptive measure Plan B ™ , sell emergency use unprotected sex , acceptable method routine use . If female become pregnant study must inform study physician immediately . Has significant risk suicide accord Columbia Suicide Severity Rating Scale ( CSSRS ) clinical judgment investigator History suicide attempt previous 12 month MDD postpartum onset , psychotic feature seasonal feature Hamilton Anxiety Scale ( HAMA ) baseline score ≥ 24 Failure ≥ 3 adequate trial different antidepressant current episode MDD ≥ 3 episode major depression previous 12 month ≥ 8 lifetime episode MDD Current previous use atypical typical antipsychotic agent augmentation major depression treatment psychotic depression , mania psychosis , agitation . Previous use antipsychotic insomnia permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>